Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Solid Phase Peptide Synthesis 2023 services provided by Bachem Ag

Bachem Ag
Solid Phase Peptide Synthesis 2023
Full Screen View

PDF Upload Jun, 2023

Bachem at Swiss Technology Award 2024

20 Sep 2024

// PRESS RELEASE

Bachem Reports Slight H1 2024 Sales Growth And Confirms Full-Year Outlook

25 Jul 2024

// PRESS RELEASE

Incident On Construction Site Of Bachem In Bubendorf

28 May 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Bachem

Contact Supplier

Bio-Europe 2024

Gold Sponsor

Book a meeting now

envelop Contact Supplier

Xls

CATEGORY PAGE

Bachem Ag

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, Pioneering Sustainable, Large-Scale Tides Manufacturing, Maintaining a Resilient Tides Supply Chain Under VUCA Conditions, Scientific Expertise to Spring 2024 Conferences, Leading the Octreotide Scale-up, Oligo Therapeutics 2024, Innovations for Tides 2024, GMP Certificate 2023, Gorerelin Leuprorelin Triptorelin 2024, Commercial Peptide NCE 2024, Molecular Hiving™ Technology, Semaglutide 2024, Lanreotide, Back to Stirred Vessels & On to Metric Tons of Oligonucleotides, Increasing Sustainability in Large Scale Peptide API Purification, Solid Phase Peptide Synthesis 2023, Purification- A Bottleneck for Oligonucleotide API Manufacturing, Manufacturing Complex Peptide APIs, Interview with Gilles Parmentier, Leadership Perspectives: Embracing Equity on Women’s Day, Annual General Meeting 2023, Innovative Approaches for Large-scale Peptide Production , Sustainability at Bachem, In Vitro Diagnostic Peptides 2023

Product List 2024
Corporate Presentation
Pioneering Sustainable, Large-Scale Tides Manufacturing
Maintaining a Resilient Tides Supply Chain Under VUCA Conditions
Scientific Expertise to Spring 2024 Conferences
Leading the Octreotide Scale-up
Oligo Therapeutics 2024
Innovations for Tides 2024
GMP Certificate 2023
Gorerelin Leuprorelin Triptorelin 2024
Commercial Peptide NCE 2024
Molecular Hiving™ Technology
Semaglutide 2024
Lanreotide
Back to Stirred Vessels & On to Metric Tons of Oligonucleotides
Increasing Sustainability in Large Scale Peptide API Purification
Solid Phase Peptide Synthesis 2023
Purification- A Bottleneck for Oligonucleotide API Manufacturing
Manufacturing Complex Peptide APIs
Interview with Gilles Parmentier
Leadership Perspectives: Embracing Equity on Women’s Day
Annual General Meeting 2023
Innovative Approaches for Large-scale Peptide Production
Sustainability at Bachem
In Vitro Diagnostic Peptides 2023

VIDEO(s)

Innovation for Peptide & Oligonucleotide Manufacturing, Peptide-based In Vitro Diagnostics, Generic APIs-Liraglutide & Other GLP-1 Analogues, Oligonucleotide Facility Virtual Tour, Semaglutide, Leading by Experience in Generic API, Customer Testimonial, Continuous Chromatography of Peptides, Expanding into Oligos - Interview, Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction, Oligonucleotides - Innovation that Transforms Lives, Interview with Torsten Wohr, The Perfect Ingredients for a Better World, Sherpany and Futurae

Innovation for Peptide & Oligonucleotide Manufacturing
Peptide-based In Vitro Diagnostics
Generic APIs-Liraglutide & Other GLP-1 Analogues
Oligonucleotide Facility Virtual Tour
Semaglutide
Leading by Experience in Generic API
Customer Testimonial
Continuous Chromatography of Peptides
Expanding into Oligos - Interview
Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction
Oligonucleotides - Innovation that Transforms Lives
Interview with Torsten Wohr
The Perfect Ingredients for a Better World
Sherpany and Futurae

DIGITAL CONTENT

39 CORPORATE CONTENT #SupplierSpotlight, 2 DATA COMPILATION #PharmaFlow, 120 NEWS #PharmaBuzz

39 CORPORATE CONTENT #SupplierSpotlight
2 DATA COMPILATION #PharmaFlow
120 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

47 All APIs, 36 USDMF, 12 CEP/COS, 12 JDMF, 10 KDMF, 46 NDC API, 6 VMF, 28 Listed APIs

47 All APIs
36 USDMF
12 CEP/COS
12 JDMF
10 KDMF
46 NDC API
6 VMF
28 Listed APIs

KEY PRODUCTS

Atosiban, Bivalirudin, Glucagon, Glucagon Hydrochloride, Goserelin Acetate, Lanreotide Acetate, Leuprolide Acetate, Leuprolide Mesylate, Octreotide Acetate, Propofol, Semaglutide, Teriparatide, Teriparatide Acetate, Triptorelin Acetate, Triptorelin Pamoate

Atosiban
Bivalirudin
Glucagon
Glucagon Hydrochloride
Goserelin Acetate
Lanreotide Acetate
Leuprolide Acetate
Leuprolide Mesylate
Octreotide Acetate
Propofol
Semaglutide
Teriparatide
Teriparatide Acetate
Triptorelin Acetate
Triptorelin Pamoate

SERVICES

Analytical, API Manufacturing, API & Drug Product Development

Analytical
- 1 Analytical Method Development
API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

Custom Peptide Synthesis, CMO for Peptide & Oligonucleotide APIs

Custom Peptide Synthesis
CMO for Peptide & Oligonucleotide APIs

INSPECTIONS & REGISTRATIONS

33 FDA, 3 EDQM, 5 GDUFA, 8 Others

33 FDA
3 EDQM
5 GDUFA
8 Others

PC100129

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?